Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis

Rafael Dal-Ré

Open source

DOI
10.1007/s00228-011-1036-1
Published
2011-04-05
Container
European Journal of Clinical Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-011-1036-1,
  title = {Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis},
  author = {Rafael Dal-Ré},
  year = {2011},
  journal = {European Journal of Clinical Pharmacology},
  doi = {10.1007/s00228-011-1036-1},
  url = {https://doi.org/10.1007/s00228-011-1036-1}
}

RIS

TY  - JOUR
TI  - Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis
AU  - Rafael Dal-Ré
PY  - 2011
JO  - European Journal of Clinical Pharmacology
DO  - 10.1007/s00228-011-1036-1
UR  - https://doi.org/10.1007/s00228-011-1036-1
ER  - 

APA

Dal-Ré, R. (2011). Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-011-1036-1

Source records